AstraZeneca has taken a key step in advancing Breztri Aerosphere toward a potential label expansion and achieving its goal of ...

More children stopped using steroid inhalers to control their asthma after GlaxoSmithKline withdrew Flovent from the market.

AstraZeneca's Breztri met primary goals in four asthma trials, including KALOS, LOGOS, LITHOS, and VATHOS, involving over ...

A Blue Cross Blue Shield policy will force some patients to self-inject medicine, with potentially dangerous results.

By Dennis Thompson HealthDay ReporterWEDNESDAY, April 30, 2025 (HealthDay News) — More children stopped using steroid ...

Dr Harish Bhatia, Founder Director of Rebreathe Clinic, Senior Chest Specialist & Director & Head Dept. Of Respiratory ...

During National Asthma and Allergy Awareness Month, the high prevalence and costs of allergies and asthma in the US are ...

A new study suggests the discontinuation of common asthma drug Flovent was linked to a higher rate of children halting inhaled steroid therapy altogether. In January 2024, a manufacturer stopped ...

GSK’s profit rose on better-than-expected performance of HIV, cancer and asthma treatments, offsetting lower vaccine demand ...